<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00914953</url>
  </required_header>
  <id_info>
    <org_study_id>CNS-R21AG029871</org_study_id>
    <secondary_id>NIH Grant 1R21AG029871-01A2</secondary_id>
    <nct_id>NCT00914953</nct_id>
  </id_info>
  <brief_title>Oxytocin and Social Behavior Over the Lifespan</brief_title>
  <official_title>Oxytocin and Social Behavior Over the Lifespan: Interventional Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Claremont Graduate University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Claremont Graduate University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will investigate if intranasal oxytocin (a hormone naturally produced in the body)&#xD;
      promotes motivation for, and engagement in, social activities in older adults.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Using a double-blind and placebo controlled design, this study seeks to determine if a short&#xD;
      course of exogenous oxytocin (OT) will induce changes in social activities in residentially&#xD;
      housed older adults (OAs) during a 10-day treatment period, and after it ends. Because OT is&#xD;
      associated with peri-reproductive behaviors, OT release in OAs is expected to be attenuated&#xD;
      relative to younger adults. If OT release is low in OAs as we hypothesize, augmenting OT may&#xD;
      increase their desire for social interactions, increase the frequency of participation in&#xD;
      social activities and augment the number of and quality of social ties, thereby providing&#xD;
      protection against disease, early death, cognitive decline, and depression. Research in&#xD;
      rodents suggests that social interactions themselves may change chronic OT levels (Carter &amp;&#xD;
      Keverne, 2002; Carter &amp; Altemus, 1997), in a positive feedback loop. In order to demonstrate&#xD;
      OT as the causal mechanism, we propose to infuse oxytocin and then track the desire for,&#xD;
      quantity of, and quality of social activities.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>confirm increased social activities in treatment condition compared to control condition via self-report.</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evidence of greater psychological health for treatment condition as compared to control condition.</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">41</enrollment>
  <condition>Social Activity</condition>
  <arm_group>
    <arm_group_label>oxytocin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>oxytocin (Pitocin)</intervention_name>
    <description>40 IU OT intranasally (IN) once-daily for 10 consecutive days</description>
    <arm_group_label>oxytocin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  residentially housed&#xD;
&#xD;
          -  English fluency&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  non ambulatory&#xD;
&#xD;
          -  severe psychiatric problems presently or in the recent past&#xD;
&#xD;
          -  severe medical problems (e.g., cancer, diabetes, advanced heart disease)&#xD;
&#xD;
          -  irregular heart beat&#xD;
&#xD;
          -  treatment using psychoactive medications (other than antiepileptics, mood stabilizers,&#xD;
             or Ambien)&#xD;
&#xD;
          -  inability to adequately communicate with the research team&#xD;
&#xD;
          -  treatment with an experimental drug&#xD;
&#xD;
          -  excessive fatigue suggesting hypothyroidism&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Linda Valley Villa</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92354-3135</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <study_first_submitted>June 4, 2009</study_first_submitted>
  <study_first_submitted_qc>June 4, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 5, 2009</study_first_posted>
  <last_update_submitted>February 29, 2012</last_update_submitted>
  <last_update_submitted_qc>February 29, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 2, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Claremont Graduate University</investigator_affiliation>
    <investigator_full_name>Paul J. Zak</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>social isolation</keyword>
  <keyword>cooperative behavior</keyword>
  <keyword>depression</keyword>
  <keyword>loneliness</keyword>
  <keyword>happiness</keyword>
  <keyword>empathy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxytocin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

